Teva- Pharmaceutical Industries Ltd. Overview
Teva- Pharmaceutical Industries Ltd. Target Price
Analysts' 12-month price predictions for TEVA.
Share Price
$17.52
Average Target Price
$22.00
25.6% upside
25.6% upside8 analysts in the last 4 months
High: $26 | Low: $20
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-09-03 | UBSAshwani Verma | $26 | 48.4% upside |  |
| 2024-08-28 | Piper SandlerDavid Amsellem | $23 | 31.3% upside | |
| 2024-08-01 | BarclaysBalaji Prasad | $22 | 25.6% upside | |
| 2024-07-10 | Argus ResearchJasper Hellweg | $20 | 14.2% upside | |
| 2024-07-10 | UBSAshwani Verma | $24 | 37% upside | |
| 2024-06-05 | BarclaysBalaji Prasad | $21 | 19.9% upside | |
| 2024-05-23 | BarclaysBalaji Prasad | $20 | 14.2% upside | |
| 2024-05-13 | Piper SandlerDavid Amsellem | $20 | 14.2% upside | |
| 2024-02-12 | Piper SandlerDavid Amsellem | $19 | 8.4% upside | |
| 2024-01-23 | JefferiesGlen Santangelo | $14 |  20.1% downside | |
| 2022-11-14 | J.P. Morgan | $10 | 42.9% downside | |
| 2022-06-13 | UBSAshwani Verma | $10 | 42.9% downside | |
| 2022-05-04 | Piper Sandler | $7 | 60% downside | |
| 2022-04-20 | BarclaysBalaji Prasad | $13 | 25.8% downside | |